方舟生物医药(ABIO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ABIO 方舟生物医药

交易中 03-31 13:28:27 EDT

28.80

+0.00

0.00%

最高28.80	最低28.80	成交量0.00
今开28.80	昨收28.80	日振幅0.00%
总市值8.49亿	流通市值1.38亿	总股本2,949万
成交额68.85万	换手率0.00%	流通股本478.82万
市净率26.07	ROE-20.05%	每股收益-0.50
52周最高53.88	52周最低18.72	市盈率-57.85
股息0.00	股息收益率0.00	ROA-14.35%

暂无数据

北京优虎网络科技有限公司

{"stockData":{"symbol":"ABIO","market":"US","secType":"STK","nameCN":"方舟生物医药","latestPrice":28.8,"timestamp":1725048000000,"preClose":28.8,"halted":8,"volume":0,"delay":0,"floatShares":4788181,"shares":29490443,"eps":-0.497828,"marketStatus":"交易中","change":0,"latestTime":"03-31 13:28:24 EDT","open":28.8,"high":28.8,"low":28.8,"amount":688505.0780728,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.497828,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1743451200000},"marketStatusCode":2,"symbolChange":{"newSymbol":"ORKA","executeDate":"2024-09-03"},"adr":0,"adrRate":0,"listingDate":871012800000,"exchange":"NASDAQ","adjPreClose":28.8,"volumeRatio":0},"requestUrl":"/m/hq/s/ABIO","defaultTab":"news","newsList":[{"id":"2460047520","title":"方舟生物医药盘中异动 股价大涨6.14%报3.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460047520","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2460047520?lang=zh_cn&edition=full","pubTime":"2024-08-20 21:40","pubTimestamp":1724161207,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日21时40分，方舟生物医药股票出现异动，股价快速上涨6.14%。截至发稿，该股报3.80美元/股，成交量3.5547万股，换手率0.25%，振幅2.93%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.68百万美元，每股收益-0.18美元，毛利-12000.00美元，市盈率-7.65倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体涨幅为0.23%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820214007a1d53b96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820214007a1d53b96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABIO","BK4139"],"gpt_icon":0},{"id":"2460348340","title":"方舟生物医药盘中异动 急速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460348340","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2460348340?lang=zh_cn&edition=full","pubTime":"2024-08-19 21:31","pubTimestamp":1724074264,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日21时31分，方舟生物医药股票出现波动，股价急速拉升5.08%。截至发稿，该股报3.10美元/股，成交量6.1761万股，换手率0.43%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体涨幅为0.00%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819213104971991de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819213104971991de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABIO"],"gpt_icon":0},{"id":"2458329777","title":"方舟生物医药盘中异动 临近收盘大幅上涨5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458329777","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2458329777?lang=zh_cn&edition=full","pubTime":"2024-08-09 03:45","pubTimestamp":1723146333,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日03时45分，方舟生物医药股票出现波动，股价大幅拉升5.78%。截至发稿，该股报2.93美元/股，成交量2.4521万股，换手率0.17%，振幅7.22%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体涨幅为3.65%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809034533968253d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809034533968253d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABIO"],"gpt_icon":0},{"id":"2457684047","title":"方舟生物医药盘中异动 早盘急速跳水6.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457684047","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2457684047?lang=zh_cn&edition=full","pubTime":"2024-08-07 22:16","pubTimestamp":1723040203,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日22时16分，方舟生物医药股票出现异动，股价快速跳水6.60%。截至发稿，该股报2.69美元/股，成交量734股，换手率0.01%，振幅9.72%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为1.90%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807221643941ff10b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807221643941ff10b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABIO","BK4139"],"gpt_icon":1},{"id":"2457677395","title":"方舟生物医药股价重挫10.61% 市值跌193.89万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457677395","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2457677395?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:45","pubTimestamp":1722865526,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时45分，方舟生物医药股票出现波动，股价大幅跳水10.61%。截至发稿，该股报2.78美元/股，成交量7448股，换手率0.05%，振幅1.61%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.68百万美元，每股收益-0.18美元，毛利-12000.00美元，市盈率-6.06倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为1.89%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805214527af95fb67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805214527af95fb67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABIO","BK4139"],"gpt_icon":0},{"id":"2456523069","title":"方舟生物医药盘中异动 急速上涨5.41%报3.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456523069","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2456523069?lang=zh_cn&edition=full","pubTime":"2024-08-03 00:57","pubTimestamp":1722617872,"startTime":"0","endTime":"0","summary":"北京时间2024年08月03日00时57分，方舟生物医药股票出现异动，股价快速上涨5.41%。截至发稿，该股报3.12美元/股，成交量2.3347万股，换手率0.16%，振幅7.77%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为1.10%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240803005752941fd9fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240803005752941fd9fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABIO"],"gpt_icon":0},{"id":"2456442354","title":"ARCA biopharma(ABIO.US)：2024年Q2财报实现营收0美元，前","url":"https://stock-news.laohu8.com/highlight/detail?id=2456442354","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2456442354?lang=zh_cn&edition=full","pubTime":"2024-08-02 12:58","pubTimestamp":1722574692,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","ABIO"],"gpt_icon":0},{"id":"2455965187","title":"方舟生物医药盘中异动 股价大跌5.16%报2.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455965187","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2455965187?lang=zh_cn&edition=full","pubTime":"2024-07-31 01:20","pubTimestamp":1722360026,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日01时20分，方舟生物医药股票出现波动，股价急速下跌5.16%。截至发稿，该股报2.94美元/股，成交量2.9924万股，换手率0.21%，振幅3.71%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为0.34%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731012026af94dfe8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731012026af94dfe8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABIO","BK4139"],"gpt_icon":0},{"id":"2454329475","title":"方舟生物医药盘中异动 股价大涨7.16%报3.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454329475","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2454329475?lang=zh_cn&edition=full","pubTime":"2024-07-26 22:51","pubTimestamp":1722005514,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日22时51分，方舟生物医药股票出现波动，股价大幅上涨7.16%。截至发稿，该股报3.29美元/股，成交量2.8248万股，换手率0.19%，振幅6.19%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体涨幅为0.38%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726225154941fb252&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726225154941fb252&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABIO"],"gpt_icon":0},{"id":"2452433799","title":"方舟生物医药盘中异动 早盘急速下挫5.16%报3.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452433799","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2452433799?lang=zh_cn&edition=full","pubTime":"2024-07-18 23:09","pubTimestamp":1721315357,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日23时09分，方舟生物医药股票出现异动，股价大幅下挫5.16%。截至发稿，该股报3.31美元/股，成交量7.3608万股，换手率0.51%，振幅8.60%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为1.08%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718230917aefa59af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718230917aefa59af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABIO"],"gpt_icon":0},{"id":"2451623038","title":"方舟生物医药盘中异动 股价大涨6.57%报3.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451623038","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2451623038?lang=zh_cn&edition=full","pubTime":"2024-07-15 21:57","pubTimestamp":1721051848,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日21时57分，方舟生物医药股票出现波动，股价急速拉升6.57%。截至发稿，该股报3.57美元/股，成交量2.2164万股，换手率0.15%，振幅1.23%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体涨幅为0.42%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715215729941f70f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715215729941f70f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABIO"],"gpt_icon":0},{"id":"2449998298","title":"方舟生物医药盘中异动 大幅下跌6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449998298","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2449998298?lang=zh_cn&edition=full","pubTime":"2024-07-05 21:35","pubTimestamp":1720186510,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日21时35分，方舟生物医药股票出现波动，股价快速跳水6.34%。截至发稿，该股报3.25美元/股，成交量2870股，换手率0.02%，振幅2.59%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体涨幅为0.65%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705213510aef82cfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705213510aef82cfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABIO","BK4139"],"gpt_icon":0},{"id":"2448633433","title":"方舟生物医药盘中异动 股价大跌5.82%报3.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448633433","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2448633433?lang=zh_cn&edition=full","pubTime":"2024-07-04 00:46","pubTimestamp":1720025178,"startTime":"0","endTime":"0","summary":"北京时间2024年07月04日00时46分，方舟生物医药股票出现波动，股价急速下挫5.82%。截至发稿，该股报3.40美元/股，成交量10.4919万股，换手率0.72%，振幅9.02%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.01百万美元，每股收益-0.14美元，毛利-19000.00美元，市盈率-8.20倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为1.67%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704004619aef7cdb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704004619aef7cdb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABIO","BK4139"],"gpt_icon":0},{"id":"2448619975","title":"方舟生物医药盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448619975","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2448619975?lang=zh_cn&edition=full","pubTime":"2024-07-03 04:01","pubTimestamp":1719950499,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日04时01分，方舟生物医药股票出现波动，股价大幅跳水5.00%。截至发稿，该股报3.61美元/股，成交量13.251万股，换手率0.91%，振幅8.95%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为0.75%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703040139941f32f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703040139941f32f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABIO","BK4139"],"gpt_icon":0},{"id":"2446685525","title":"方舟生物医药盘中异动 股价大涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446685525","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2446685525?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:47","pubTimestamp":1719582438,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日21时47分，方舟生物医药股票出现异动，股价快速拉升5.38%。截至发稿，该股报3.79美元/股，成交量6901股，换手率0.05%，振幅0.07%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体涨幅为0.03%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628214719aef729a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628214719aef729a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABIO","BK4139"],"gpt_icon":0},{"id":"2443675524","title":"方舟生物医药盘中异动 早盘急速跳水5.07%报3.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443675524","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2443675524?lang=zh_cn&edition=full","pubTime":"2024-06-14 21:54","pubTimestamp":1718373283,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日21时54分，方舟生物医药股票出现异动，股价急速跳水5.07%。截至发稿，该股报3.15美元/股，成交量6565股，换手率0.05%，振幅4.16%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为0.01%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614215444aef50953&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614215444aef50953&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABIO"],"gpt_icon":0},{"id":"2442842667","title":"方舟生物医药盘中异动 早盘急速跳水8.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442842667","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2442842667?lang=zh_cn&edition=full","pubTime":"2024-06-10 21:32","pubTimestamp":1718026333,"startTime":"0","endTime":"0","summary":"北京时间2024年06月10日21时32分，方舟生物医药股票出现异动，股价大幅跳水8.54%。截至发稿，该股报3.00美元/股，成交量4.3777万股，换手率0.30%，振幅3.05%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为0.49%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061021321395a0bd26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061021321395a0bd26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABIO","BK4139"],"gpt_icon":0},{"id":"2440796235","title":"方舟生物医药盘中异动 股价大涨5.09%报3.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440796235","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2440796235?lang=zh_cn&edition=full","pubTime":"2024-06-04 21:31","pubTimestamp":1717507882,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日21时31分，方舟生物医药股票出现波动，股价快速上涨5.09%。截至发稿，该股报3.92美元/股，成交量2.615万股，换手率0.18%，振幅4.92%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体涨幅为0.16%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406042131229f19160f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406042131229f19160f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABIO"],"gpt_icon":0},{"id":"2440349345","title":"方舟生物医药盘中异动 股价大涨6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440349345","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2440349345?lang=zh_cn&edition=full","pubTime":"2024-06-03 21:31","pubTimestamp":1717421506,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日21时31分，方舟生物医药股票出现异动，股价大幅拉升6.08%。截至发稿，该股报3.93美元/股，成交量6.2683万股，换手率0.43%，振幅2.70%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为0.35%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406032131479f156b7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406032131479f156b7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABIO","BK4139"],"gpt_icon":0},{"id":"2440944772","title":"方舟生物医药盘中异动 大幅拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440944772","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2440944772?lang=zh_cn&edition=full","pubTime":"2024-06-01 03:15","pubTimestamp":1717182930,"startTime":"0","endTime":"0","summary":"北京时间2024年06月01日03时15分，方舟生物医药股票出现波动，股价大幅拉升5.19%。截至发稿，该股报3.65美元/股，成交量4.3095万股，换手率0.30%，振幅4.61%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体涨幅为0.62%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601031531aef2d25c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601031531aef2d25c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABIO","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arcabiopharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0.3636},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0148},{"period":"1month","weight":-0.0654},{"period":"3month","weight":-0.0661},{"period":"6month","weight":-0.0277},{"period":"1year","weight":0.0623},{"period":"ytd","weight":-0.0519}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"方舟生物医药公司是一家生物制药公司,该公司主要致力于心血管疾病的基因疗法。公司的领先候选产品是Gencaro TM，一种有效的β受体阻滞剂同时还是温和的血管舒张药，正被开发用于治疗心房纤维颤动患者的心脏衰竭。公司已经识别出在心血管系统中常见的基因变异，并认为这与Gencaro的药理有关，并能预测病人对药物的反应。2009年1月27日，公司根据并购重组条款与ARCA科罗拉多完成业务合并，Nuvelo公司的全资子公司并入ARCA科罗拉多，ARCA科罗拉多州继续作为合并存续公司并成为Nuvelo公司的子公司，合并后，公司从Nuvelo更名为ARCA生物制药公司。Nuvelo最初注册名为Hyseq公司，于1992年在伊利诺伊州注册，并于1993年在内华达州重新注册。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.061348},{"month":2,"riseRate":0.375,"avgChangeRate":-0.063833},{"month":3,"riseRate":0.3125,"avgChangeRate":-0.030249},{"month":4,"riseRate":0.5625,"avgChangeRate":0.101192},{"month":5,"riseRate":0.5,"avgChangeRate":0.09678},{"month":6,"riseRate":0.25,"avgChangeRate":0.477078},{"month":7,"riseRate":0.5,"avgChangeRate":0.014024},{"month":8,"riseRate":0.0625,"avgChangeRate":-0.146138},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.075747},{"month":10,"riseRate":0.4,"avgChangeRate":-0.066754},{"month":11,"riseRate":0.666667,"avgChangeRate":0.018484},{"month":12,"riseRate":0.533333,"avgChangeRate":0.003511}],"exchange":"NASDAQ","name":"方舟生物医药","nameEN":"ARCA biopharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"方舟生物医药(ABIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供方舟生物医药(ABIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"方舟生物医药,ABIO,方舟生物医药股票,方舟生物医药股票老虎,方舟生物医药股票老虎国际,方舟生物医药行情,方舟生物医药股票行情,方舟生物医药股价,方舟生物医药股市,方舟生物医药股票价格,方舟生物医药股票交易,方舟生物医药股票购买,方舟生物医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"方舟生物医药(ABIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供方舟生物医药(ABIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}